Investor Alert

Company Close Updates Archives | Email alerts

Nov. 18, 2020, 5:01 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock remains steady Wednesday, still outperforms market

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP were unchanged Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.82% to 11,801.60 and Dow Jones Industrial Average DJIA falling 1.16% to 29,438.42. Corbus Pharmaceuticals Holdings Inc. closed $8.58 short of its 52-week high ($9.78), which the company reached on August 31st.

The stock outperformed some of its competitors Wednesday, as Fate Therapeutics Inc. FATE fell 5.15% to $49.72, Vanda Pharmaceuticals Inc. VNDA fell 3.25% to $12.82, and Viking Therapeutics Inc. VKTX fell 2.49% to $6.26. Trading volume (3.7 M) remained 1.6 million below its 50-day average volume of 5.3 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.